HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Norbert Gattermann Selected Research

Refractory Anemia with Excess of Blasts (RAEM)

12/2013Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome.
4/2010Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.
11/2007Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes.
12/2006Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
1/2006Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.
2/2004Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Norbert Gattermann Research Topics

Disease

32Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2015 - 11/2002
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2011 - 11/2002
8Iron Overload
12/2013 - 12/2007
6Refractory Anemia with Excess of Blasts (RAEM)
12/2013 - 02/2004
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2011 - 11/2002
4Refractory Anemia
07/2012 - 01/2002
4Anemia
04/2010 - 07/2006
3Neoplasms (Cancer)
02/2012 - 11/2002
2Exanthema (Rash)
03/2012 - 02/2008
2Thalassemia
01/2012 - 07/2009
2Myeloproliferative Disorders (Myeloproliferative Disorder)
05/2008 - 11/2005
2Blast Crisis (Blast Phase)
12/2006 - 01/2003
1Inflammation
12/2013
1Thrombocytosis (Thrombocythemia)
07/2012
1Polycythemia (Erythrocytosis)
01/2012
1Aneurysm (Aneurysms)
01/2012
1Hemosiderosis
04/2010
1Thrombocytopenia (Thrombopenia)
11/2009
1Hemochromatosis (Bronze Diabetes)
07/2009
1Uniparental Disomy
07/2008
1Systemic Mastocytosis
07/2008
1Hemorrhage
07/2008
1Philadelphia Chromosome
11/2007
1Acute Promyelocytic Leukemia
11/2007
1Essential Thrombocythemia
11/2005
1Primary Myelofibrosis (Myelosclerosis)
11/2005
1Polycythemia Vera
11/2005
1Leukemia
01/2003
1Lymphoma (Lymphomas)
11/2002
1Hematologic Neoplasms (Hematological Malignancy)
11/2002

Drug/Important Bio-Agent (IBA)

14IronIBA
10/2015 - 01/2002
7Azacitidine (5 Azacytidine)FDA Link
12/2014 - 03/2009
6deferasiroxFDA Link
10/2015 - 02/2008
4Valproic Acid (Valproate, Semisodium)FDA LinkGeneric
08/2011 - 09/2004
4imatinib (Gleevec)FDA Link
01/2011 - 12/2006
4Bcr-Abl tyrosine kinaseIBA
01/2011 - 12/2006
3Ferritins (Ferritin)IBA
12/2013 - 04/2010
34- methyl- N- (3- (4- methylimidazol- 1- yl)- 5- (trifluoromethyl)phenyl)- 3- ((4- pyridin- 3- ylpyrimidin- 2- yl)amino)benzamide (nilotinib)FDA Link
01/2011 - 11/2007
3Cytarabine (Cytosar-U)FDA LinkGeneric
04/2010 - 12/2006
35q- syndromeIBA
07/2008 - 12/2006
3Histone Deacetylases (Histone Deacetylase)IBA
01/2006 - 09/2004
3Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2006 - 09/2004
2hepcidinIBA
12/2013 - 12/2013
2Janus Kinase 2IBA
07/2012 - 11/2005
2CreatinineIBA
03/2012 - 02/2008
2N 30IBA
02/2012 - 02/2008
2Dietary IronIBA
01/2012 - 01/2011
2Mitochondrial DNA (mtDNA)IBA
06/2011 - 05/2008
1iodonitrotetrazolium (INT)IBA
12/2014
1Transferrin (beta 2 Transferrin)IBA
12/2013
1C-Reactive ProteinIBA
12/2013
1tranilast (N 5')IBA
12/2013
1Transferrin Receptors (Transferrin Receptor)IBA
12/2013
1Hemoglobins (Hemoglobin)IBA
12/2013
1ErythropoietinFDA Link
12/2013
1hemoglobin YorkIBA
01/2012
1Chelating AgentsIBA
01/2012
1OxygenIBA
01/2012
1decitabine (5-aza-2'-deoxycytidine)FDA Link
11/2009
1tipifarnib (R115777)IBA
11/2009
1Amino AcidsFDA Link
02/2009
1beta 2-Microglobulin (beta 2 Microglobulin)IBA
02/2009
1Heparin (Liquaemin)FDA LinkGeneric
07/2008
1DNA (Deoxyribonucleic Acid)IBA
07/2008
1DiamondIBA
02/2008
1arsenic trioxide (Trisenox)FDA Link
11/2007
1ArsenicIBA
11/2007
1ProteomeIBA
01/2007
1LigandsIBA
01/2007
1Interferon-alpha (Interferon Alfa)FDA Link
12/2006
1Pyridoxine (Pyridoxin)FDA LinkGeneric
07/2006
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2005
1Azathioprine (Imuran)FDA LinkGeneric
05/2005
1Transfer RNA (tRNA)IBA
02/2004
1Leu Transfer RNAIBA
02/2004
1Messenger RNA (mRNA)IBA
01/2003
1fludarabineIBA
11/2002

Therapy/Procedure

8Chelation Therapy (Therapy, Chelation)
10/2015 - 12/2007
7Drug Therapy (Chemotherapy)
02/2012 - 11/2002
3Stem Cell Transplantation
01/2006 - 11/2002
2Erythrocyte Transfusion
12/2013 - 07/2008
1Surgical Instruments (Clip)
01/2012
1Blood Transfusion (Blood Transfusions)
01/2011
1Cell Transplantation
01/2010
1Platelet Transfusion (Blood Platelet Transfusions)
11/2009
1Hematopoietic Stem Cell Transplantation
05/2009
1Transplants (Transplant)
11/2002